Page last updated: 2024-11-04

mimosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Mimosine is a non-protein amino acid found in the legume plant Mimosa pudica, also known as the sensitive plant. It is a naturally occurring compound that exhibits a variety of biological activities, including anti-cancer, anti-inflammatory, and antimicrobial properties. Mimosine is synthesized in plants through a complex series of enzymatic reactions involving the amino acid tyrosine. One of its most notable effects is its ability to inhibit the growth of hair and skin cells, which has led to its investigation as a potential therapeutic agent for conditions like alopecia and psoriasis. Mimosine's effects on hair growth are attributed to its ability to interfere with the production of melanin, the pigment that gives hair its color. Research has shown that mimosine can cause hair loss and depigmentation in animals. The study of mimosine has garnered interest due to its potential applications in medicine and agriculture. Its anti-cancer properties are being explored for the development of new cancer therapies. In agriculture, mimosine has been investigated as a potential natural herbicide due to its toxicity to some weed species. However, its use is limited due to its toxicity to other plants, including legumes.'

L-mimosine : An L-alpha-amino acid that is propionic acid substituted by an amino group at position 2 and a 3-hydroxy-4-oxopyridin-1(4H)-yl group at position 3 (the 2S-stereoisomer). It a non-protein plant amino acid isolated from Mimosa pudica. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Mimosine: 3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
MimosagenusA plant genus of the family FABACEAE that contains kukulkanin, a CHALCONE.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID440473
CHEMBL ID245416
CHEBI ID29063
SCHEMBL ID41925
MeSH IDM0013894
PubMed CID3862
CHEMBL ID251433
CHEBI ID95190
SCHEMBL ID41924
MeSH IDM0013894

Synonyms (153)

Synonym
BIDD:ER0500
1(4h)-pyridinepropanoic acid, alpha-amino-3-hydroxy-4-oxo-, (s)-
minosine, l-
hsdb 3512
einecs 207-905-1
ai3-51821
nsc 69188
z46b1lui5n ,
(s)-alpha-amino-3-hydroxy-4-oxo-1(4h)-pyridylpropionic acid
1(4h)-pyridinepropanoic acid, alpha-amino-3-hydroxy-4-oxo-, (alphas)-
unii-z46b1lui5n
CHEBI:29063 ,
(2s)-2-amino-3-(3-hydroxy-4-oxopyridin-1(4h)-yl)propanoic acid
BIO1_001334
BIO1_000845
BIO1_000356
NCGC00179528-01
mimosin
(2s)-2-amino-3-(3-hydroxy-4-oxo-1-pyridyl)propanoic acid
(2s)-2-amino-3-[3-hydroxy-4-oxo-1(4h)-pyridyl]propanoic acid
leucenine
BPBIO1_000591
BSPBIO_000537
PRESTWICK3_000379
AB00513825
l-mimosine
C04771
leucenol
500-44-7
leucaenol
leucaenine
l-mimosine from koa hoale seeds, >=98%
DB01055
(l)-mimosine
M-7300
bdbm50198715
NCGC00179528-02
CHEMBL245416 ,
(2s)-2-amino-3-(3-hydroxy-4-oxopyridin-1-yl)propanoic acid
HMS3263H18
HMS2096K19
l-mimosine from koa hoale seeds
LP01238
S7446
CCG-208235
WZNJWVWKTVETCG-YFKPBYRVSA-N
1-mimosine
SCHEMBL41925
(2s)-2-azaniumyl-3-(4-hydroxy-3-oxidopyridinium-1-yl)propanoate
NCGC00261923-01
tox21_501238
l-leucinine
AC-35157
mimosine [who-dd]
mimosine [mi]
mfcd00075909
(2s)-2-amino-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)propanoic acid
AKOS027326907
SR-05000002336-3
SR-05000002336-2
sr-05000002336
NCGC00179528-04
3-(3-hydroxy-4-oxopyridin-1(4h)-yl)-l-alanine
Q3180669
(s)-2-amino-3-(3-hydroxy-4-oxopyridin-1(4h)-yl)propanoic acid
DTXSID401017244
A14279
SDCCGSBI-0633809.P001
NCGC00179528-07
A853611
AS-56262
CS-0012957
HY-N0928
STARBLD0036637
2-amino-3-(3-hydroxy-4-oxo-pyridin-1-yl)propanoic acid
DIVK1C_001000
KBIO1_001000
NCI60_032990
SDCCGMLS-0066728.P001
leucena glauca .alpha.-amino acid
1(4h)-pyridinepropanoic acid, (s)-
nsc-69188
SPECTRUM_000287
PRESTWICK_830
PRESTWICK2_000379
NCGC00178740-01
NSC69188 ,
IDI1_001000
BSPBIO_002244
SPECTRUM5_001484
.beta.-[n-(3-hydroxy-4-pyridone)]-.alpha.-aminopropionic acid
nsc-159548
1(4h)-pyridinepropionic acid, .alpha.-amino-3-hydroxy-4-oxo-
10182-82-8
mimosine
1(4h)-pyridinealanine, 3-hydroxy-4-oxo-
wln: t6n dvj a1yzvq cq
nsc159548 ,
NCGC00094870-01
NCGC00094870-02
KBIO2_000767
KBIO3_001464
KBIO2_005903
KBIOSS_000767
KBIOGR_000440
KBIO2_003335
SPECTRUM2_000656
PRESTWICK1_000379
PRESTWICK0_000379
SPECTRUM3_000722
SPECTRUM4_000110
SPBIO_000691
NINDS_001000
SPBIO_002458
SPECTRUM1500869
CHEMBL251433
HMS503G21
HMS1921M08
HMS1569K19
2-amino-3-(3-hydroxy-4-oxopyridin-1-yl)propanoic acid
NCGC00094870-03
AKOS006228368
CCG-38561
x9w047ul80 ,
2116-55-4
1(4h)-pyridinepropanoic acid, alpha-amino-3-hydroxy-4-oxo-, (+-)-
1(4h)-pyridinepropanoic acid, alpha-amino-3-hydroxy-4-oxo-
dl-mimosine
mimosine, (+/-)-
1-l-alpha-aminopropionil, 3-hydroxi, 4-oxopiridina [spanish]
nsc 159548
unii-x9w047ul80
FT-0627961
SCHEMBL41924
1(4h)-pyridinepropanoic acid, .alpha.-amino-3-hydroxy-4-oxo-
1(4h)-pyridinepropanoic acid, .alpha.-amino-3-hydroxy-4-oxo-, (.alpha.s)-
mimosine, dl-
mimosine dl-form [mi]
CHEBI:95190
2-amino-3-(3-hydroxy-4-oxo-1h-pyridin-1-yl)-propanoic acid
2-amino-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)propanoic acid
(+/-)-mimosine
Q27166999
leucenine;leucenol
BCP13303
HMS3744K15
STL564778
2-amino-3-(3-hydroxy-4-oxopyridin-1(4h)-yl)propanoic acid
3-(3-hydroxy-4-oxopyridin-1(4h)-yl)alanine
27678-82-6
DTXSID80950337
CS-0119397
STARBLD0038733

Research Excerpts

Overview

L-mimosine is a non-protein amino acid derived from plants known for its ability to bind to divalent and trivalent metal cations such as Zn. It has been reported to exhibit antitumor activity in a number of types of cancer.

ExcerptReferenceRelevance
"L-mimosine is a compound found in Leucaena leucocephala, that is used as animal feed due to its high protein content, but it can also cause intoxication. "( Alternative method for oral administration of insoluble toxins to rats. A prenatal study of L-mimosine.
de Almeida, ERM; Hueza, IM; Martinelli, ECL; Pereira, EC; Raspantini, LER, 2021
)
1.56
"Mimosine is a nonprotein amino acid derived from plants known for its ability to bind to divalent and trivalent metal cations such as Zn"( Influence of the Nonprotein Amino Acid Mimosine in Peptide Conformational Propensities from Novel Amber Force Field Parameters.
De Sancho, D; López, X; Urriolabeitia, A, 2022
)
2.43
"Mimosine is a nonprotein amino acid biosynthesized from OAS (O-acetylserine) and 3H4P (3-hydroxy-4-pyridone or its tautoisomer 3,4-dihydroxypyridine). "( Methods of Mimosine Extraction from Leucaena leucocephala (Lam.) de Wit Leaves.
Borthakur, D; da Silva Rodrigues-Honda, KC; Fett-Neto, AG; Honda, MDH, 2022
)
2.55
"Mimosine is a non-protein amino acid with various properties, such as antibacterial, anti-inflammatory, anti-cancer and anti-virus among others. "( Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agents.
Bachor, R; Cappai, R; Cosentino, S; Dalla Torre, G; Ibba, A; Jaremko, L; Jaremko, M; Lachowicz, JI; Lopez, X; Mujika, J; Nurchi, VM; Orrù, G; Pisano, MB; Randaccio, E; Szewczuk, Z, 2020
)
2.32
"L-mimosine is a rare plant amino acid extracted from Mimosa or Leucaena spp., and it has been reported to exhibit antitumor activity in a number of types of cancer. "( L‑mimosine induces caspase‑9‑mediated apoptosis in human osteosarcoma cells.
Cai, L; Xu, Y, 2018
)
1.92
"Mimosine is a non-protein amino acid of Fabaceae, such as Leucaena spp. "( Mimosine accumulation in Leucaena leucocephala in response to stress signaling molecules and acute UV exposure.
Borthakur, D; Fett-Neto, AG; Honda, MDH; Rodrigues-Corrêa, KCDS, 2019
)
3.4
"Mimosine is an effective cell synchronization reagent used for arresting cells in late G1 phase. "( Activation of the prereplication complex is blocked by mimosine through reactive oxygen species-activated ataxia telangiectasia mutated (ATM) protein without DNA damage.
Aoyama, K; Fukumoto, Y; Ishibashi, K; Kubota, S; Nakayama, Y; Soeda, S; Yamaguchi, N; Yuki, R, 2014
)
2.09
"Mimosine is a leading compound of interest for use in the development of RAC/CDC42-activated kinase 1 (PAK1)-specific inhibitors for the treatment of various diseases/disorders, because PAK1 is not essential for the growth of normal cells."( The Chemistry and Biological Activities of Mimosine: A Review.
Nguyen, BC; Tawata, S, 2016
)
1.42
"Mimosine, which is a natural plant amino acid present in the Leucaena genus, is able to induce hypoxia‑inducible factors (HIFs). "( Attenuation of prostaglandin E1‑induced osteoprotegerin synthesis in osteoblasts by normoxic HIF inducers.
Fujita, K; Kainuma, S; Kozawa, O; Kuroyanagi, G; Matsushima-Nishiwaki, R; Ohguchi, R; Otsuka, T; Tokuda, H; Yamamoto, N, 2017
)
1.9
"Mimosine is a rare plant amino acid that arrests the cell cycle in the G(1) phase before entry into S phase."( Mimosine arrests the cell cycle prior to the onset of DNA replication by preventing the binding of human Ctf4/And-1 to chromatin via Hif-1α activation in HeLa cells.
Im, JS; Kim, SE; Lee, JK; Park, SR; Park, SY; Wang, HJ, 2012
)
2.54
"Mimosine is a toxin present in the tree-legume leucaena (Leucaena leucocephala), including its root nodules and the root exudates. "( The mid genes of Rhizobium sp strain TAL1145 are required for degradation of mimosine into 3-hydroxy-4-pyridone and are inducible by mimosine.
Borthakur, D; Fox, PM; Soedarjo, M; Webb, DT, 2003
)
1.99
"L-mimosine is a naturally occurring plant amino acid and iron chelator that arrests the cell cycle in the late G(1) phase, although its mechanism of action is not known. "( Mimosine attenuates serine hydroxymethyltransferase transcription by chelating zinc. Implications for inhibition of DNA replication.
Nasrallah, IM; Perry, C; Sastry, R; Stover, PJ, 2005
)
2.49
"Mimosine is a plant amino-acid which has been reported to block DNA replication in mammalian cells and to arrest cell reversibly towards the end of the G1 phase or at the beginning of the S phase. "( Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound L-mimosine.
Brellou, G; Castellani, ML; Conti, P; Frydas, S; Grilli, A; Hatzistilianou, M; Karagouni, E; Papaioannou, N; Papazahariadou, M; Patruno, A; Petrarca, C; Riccioni, G; Trakatelli, M,
)
1.79
"Mimosine is a toxic nonprotein amino acid that is a major constituent of the tropical legumes Leucaena and Mimosa. "( Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells.
Kulp, KS; Vulliet, PR, 1996
)
3.18
"Mimosine is a potent reversible late G1 phase blocker of the cell cycle."( p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine.
Alpan, RS; Pardee, AB, 1996
)
1.25
"Mimosine is a non-toxic plant aminoacid which is an effective inhibitor of DNA replication by acting at the S-phase. "( Inhibition of MCP-1 and MIP-2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis.
Barbacane, RC; Conti, P; Di Gioacchino, M; Felaco, M; Frydas, S; Reale, M; Trakatellis, A, 2002
)
2

Effects

Mimosine is one of the principal non-protein amino acids that occurs in all organs. It has been used experimentally as a cell cycle G1/S phase transition blocker. Mimosine has been shown to cause acute and chronic toxicosis in livestock fed from forage containing these plants.

ExcerptReferenceRelevance
"Mimosine has been detected in leaves, flowers, pods, seeds, and roots, and it is one of the principal non-protein amino acids that occurs in all organs."( The co-occurrence of two pyridine alkaloids, mimosine and trigonelline, in Leucaena leucocephala.
Ashihara, H; Kato, M; Ogita, S; Watanabe, S,
)
1.11
"Mimosine has been used experimentally as a cell cycle G1/S phase transition blocker (Lalande: Exp Cell Res 186:332-339, 1990; Hoffman et al.: Cytometry 12:26-32, 1991)."( Mimosine prevents the death of glucose-deprived immunostimulated astrocytes by scavenging peroxynitrite.
Choi, JJ; Kim, HC; Kim, HS; Kim, WK; Ko, KH; Oh, YK, 2002
)
2.48
"Mimosine has been reported to specifically prevent initiation of DNA replication in the chromosomes of mammalian nuclei. "( Mimosine arrests DNA synthesis at replication forks by inhibiting deoxyribonucleotide metabolism.
Burhans, WC; DePamphilis, ML; Gilbert, DM; Miyazawa, H; Neilson, A, 1995
)
3.18
"Mimosine has been shown to cause acute and chronic toxicosis in livestock fed from forage containing these plants."( Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells.
Kulp, KS; Vulliet, PR, 1996
)
2.46

Actions

Mimosine did not cause defleecing in the area of infusion and was cleared from the bloodstream within 12 h. Mimosine was shown to inhibit the incorporation at a concentration of 0-2 mM.

ExcerptReferenceRelevance
"Mimosine did not cause defleecing in the area of infusion and was cleared from the bloodstream within 12 h of cessation of infusion."( Effects of mimosine administered to a perfused area of skin in Angora goats.
Hart, SP; Pierzynowski, SG; Puchała, R; Sahlu, T, 1996
)
1.41
"Mimosine was shown to inhibit the incorporation at a concentration of 0-2 mM."( Inhibition of wool follicle DNA synthesis by mimosine and related 4(1H)-pyridones.
Harris, RL; Ward, KA, 1976
)
1.24

Treatment

Mimosine treatment of pig GCs for 24h resulted in proliferation arrest in vitro. Mimosine-treated neural precursor cells injected into established intracerebral CNS-1 gliomas in nude mice migrated throughout the tumor and into the surrounding parenchyma.

ExcerptReferenceRelevance
"Mimosine treatment activates ataxia telangiectasia mutated (ATM)/ataxia telangiectasia and Rad3-related (ATR)-mediated checkpoint signaling without inducing DNA damage."( Activation of the prereplication complex is blocked by mimosine through reactive oxygen species-activated ataxia telangiectasia mutated (ATM) protein without DNA damage.
Aoyama, K; Fukumoto, Y; Ishibashi, K; Kubota, S; Nakayama, Y; Soeda, S; Yamaguchi, N; Yuki, R, 2014
)
1.37
"L-Mimosine treatment decreased cyclin D1 protein in PC-3 cells, but not in LNCaP cells."( L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.
Chang, PL; Chung, LC; Feng, TH; Juang, HH; Lee, SL; Tsui, KH, 2012
)
1.66
"Mimosine treatment of pig GCs for 24h resulted in proliferation arrest in vitro."( Cell cycle synchronization of porcine granulosa cells in G1 stage with mimosine.
Engelová, M; Marinov, I; Tománek, M; Vacková, I, 2003
)
1.27
"Mimosine treatment resulted in a significant tumor growth suppression and the sub-G1 fraction was doubled (10.82 +/- 1.18% vs. "( Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts.
Bocsi, J; Zalatnai, A,
)
3.02
"Mimosine treatment eliminated MRE- and Sp1-binding activity in nuclear extracts from MCF-7 cells but not in nuclear extracts from a mimosine-resistant cell line, MCF-7/2a."( Mimosine attenuates serine hydroxymethyltransferase transcription by chelating zinc. Implications for inhibition of DNA replication.
Nasrallah, IM; Perry, C; Sastry, R; Stover, PJ, 2005
)
2.49
"Mimosine treatment did not alter p34cdc2 synthesis or turnover; however, overall phosphorylation of p34cdc2 was decreased to near undetectable levels."( Dissociation of p34cdc2 complex formation from phosphorylation and histone H1 kinase activity.
Burnette, RJ; Eblen, ST; Fautsch, MP; Leof, EB; Snyder, M, 1995
)
1.01
"Mimosine-treated neural precursor cells injected into established intracerebral CNS-1 gliomas in nude mice migrated extensively throughout the tumor and into the surrounding parenchyma beyond the tumor over 3 days."( Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.
Aboody, KS; Breakefield, XO; Herrlinger, U; Jacobs, AH; Rainov, NG; Sena-Esteves, M; Snyder, EY; Woiciechowski, C, 2000
)
1.03
"Mimosine treatment resulted in cell cycle blocks at the G(1)/S-phase border and in S phase."( Radiation sensitization of mammalian cells by metal chelators.
Cook, J, 2001
)
1.03
"Mimosine treatment resulted in upregulation of p27(Kip1) and P-gp, whereas p21(WAF-1) remained unchanged."( Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors.
Fischer, K; Hescheler, J; Sauer, H; Wartenberg, M, 2002
)
1.04
"Treatment with mimosine blocked the increase of nitrotyrosine immunoreactivity, a marker of peroxynitrite, in glucose-deprived immunostimulated astrocytes."( Mimosine prevents the death of glucose-deprived immunostimulated astrocytes by scavenging peroxynitrite.
Choi, JJ; Kim, HC; Kim, HS; Kim, WK; Ko, KH; Oh, YK, 2002
)
2.1
"Treatment with mimosine and colchicine or exposure to heat shock or anoxia results in upregulation of NvGas6 expression."( Newt orthologue of Growth arrest-specific 6 (NvGas6) is implicated in stress response during newt forelimb regeneration.
Beug, S; Tsilfidis, C; Vascotto, SG, 2006
)
0.67

Toxicity

Leucaena leucocephala is a worldwide plant used as forage. Its use in animal production has been limited because of the presence of a toxic nonprotein amino acid, L-mimosine. Cattle and goats in Australia lack the ability to totally degrade 3-hydroxy-4(1H)-pyridone.

ExcerptReferenceRelevance
"Cattle and goats in Australia lack the ability to totally degrade 3-hydroxy-4(1H)-pyridone, also known as 3,4-dihydroxy pyridine (3,4 DHP), the ruminal metabolite of mimosine, a toxic aminoacid present in the leguminous shrub Leucaena leucocephala."( Successful transfer of DHP-degrading bacteria from Hawaiian goats to Australian ruminants to overcome the toxicity of Leucaena.
Jones, RJ; Megarrity, RG, 1986
)
0.47
"Leucaena leucocephala is a worldwide plant used as forage; however, its use in animal production has been limited because of the presence of a toxic nonprotein amino acid, L-mimosine."( Potential toxic effects produced by L-mimosine in the thyroid and reproductive systems. Evaluation in male rats.
Almeida, ERM; Dipe, VV; Górniak, SL; Gotardo, AT; Hueza, IM; Pfister, JA, 2021
)
1.09

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" Physical stressors included thermogenic microwave radiation (2,450 MHz, mean specific absorption rate of 91 W/kg) and conventional heating with hot air or hot-water bath."( Physiologic aging of mature porcine erythrocytes: effects of various metabolites, antimetabolites, and physical stressors.
Erwin, DN; Kiel, JL, 1986
)
0.27

Dosage Studied

The knowledge gained at the cellular and molecular levels, and biological activities of PSMs would be useful in planning for future epidemiological studies and human cancer prevention trials.

ExcerptRelevanceReference
"Twenty-two Merino sheep were dosed with various amounts of L-mimosine, given either as an intravenous or an intraperitoneal injection, or as a continuous intravenous infusion for periods of 1-4 days."( Effects of mimosine, a potential chemical defleecing agent, on wool growth and the skin of sheep.
Chapman, RE; Reis, PJ; Tunks, DA, 1975
)
0.89
" Comparison of dose-response data for plasmid relaxation with that obtained from SQ-20B cells enabled a direct estimation of supercoil target size in these cells."( Topologically constrained domains of supercoiled DNA in eukaryotic cells.
Constantinou, A; Khodarev, NN; Narayana, A; Vaughan, AT, 1997
)
0.3
" In another experiment, oral dosing of eight Angora bucks (23+/-."( Effects of mimosine and 2,3-dihydroxypyridine on fiber shedding in Angora goats.
Goetsch, AL; Puchala, R; Reis, PJ; Sahlu, T, 1999
)
0.69
" The knowledge gained at the cellular and molecular levels, and biological activities of PSMs including tannin-polyphenols, saponins, mimosine, flavonoids, terpenoids, and phytates, would be useful in planning for future epidemiological studies and human cancer prevention trials, especially when a large pure dosage is not the option to deliver the active compounds to many tissues."( Potential therapeutic applications of some antinutritional plant secondary metabolites.
Bhat, TK; Singh, B, 2003
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
EC 1.14.18.1 (tyrosinase) inhibitorAny EC 1.14.18.* (oxidoreductase acting on paired donors, miscellaneous compound as one donor, incorporating 1 atom of oxygen) inhibitor that interferes with the action of tyrosinase (monophenol monooxygenase), EC 1.14.18.1, an enzyme that catalyses the oxidation of phenols (such as tyrosine) and is widespread in plants and animals.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
4-pyridonesAny pyridone that is pyridin-4-one or its derivatives by substitution of one of more of the hydrogens.
alpha-amino acidAn amino acid in which the amino group is located on the carbon atom at the position alpha to the carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thioredoxin reductaseRattus norvegicus (Norway rat)Potency0.35710.100020.879379.4328AID588453; AID588456
GLS proteinHomo sapiens (human)Potency15.84890.35487.935539.8107AID624146
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency10.00000.035520.977089.1251AID504332
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency37.93300.060110.745337.9330AID485368
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency39.81070.177814.390939.8107AID2147
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)3.68000.03403.987110.0000AID305365; AID309025; AID740438
TyrosinaseHomo sapiens (human)IC50 (µMol)3.68000.02304.459310.0000AID1799678
TyrosinaseHomo sapiens (human)Ki10.30001.70004.73339.1000AID1717728
Polyphenol oxidase 1Agaricus bisporusIC50 (µMol)3.68001.40002.54003.6800AID1802947
Deoxyhypusine hydroxylaseHomo sapiens (human)IC50 (µMol)5.00005.00005.00005.0000AID1601772
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (12)

Processvia Protein(s)Taxonomy
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
peptidyl-lysine modification to peptidyl-hypusineDeoxyhypusine hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
iron ion bindingDeoxyhypusine hydroxylaseHomo sapiens (human)
protein bindingDeoxyhypusine hydroxylaseHomo sapiens (human)
deoxyhypusine monooxygenase activityDeoxyhypusine hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
cellular_componentDeoxyhypusine hydroxylaseHomo sapiens (human)
cytosolDeoxyhypusine hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (48)

Assay IDTitleYearJournalArticle
AID1802947In Vitro Tyrosinase Inhibition Assay from Article 10.3109/14756366.2010.482529: \\Tyrosinase inhibitory effect of benzoic acid derivatives and their structure-activity relationships.\\2010Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 25, Issue:6
Tyrosinase inhibitory effect of benzoic acid derivatives and their structure-activity relationships.
AID1799678Inhibition Assay from Article 10.1080/14756360500179333: \\Tyrosinase inhibition: conformational analysis based studies on molecular dynamics calculations of bipiperidine based inhibitors.\\2005Journal of enzyme inhibition and medicinal chemistry, Aug, Volume: 20, Issue:4
Tyrosinase inhibition: conformational analysis based studies on molecular dynamics calculations of bipiperidine based inhibitors.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID740438Inhibition of diphenolase activity of mushroom tyrosinase assessed as decrease in L-DOPA chrome formation using L-DOPA as substrate preincubated with enzyme for 10 mins prior to substrate addition measured for 10 mins by spectrophotometric assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Synthesis of novel azo compounds containing 5(4H)-oxazolone ring as potent tyrosinase inhibitors.
AID312521Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum2008Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
In search of novel agents for therapy of tropical diseases and human immunodeficiency virus.
AID305365Inhibition of mushroom tyrosinase after 10 mins2007Bioorganic & medicinal chemistry, Feb-01, Volume: 15, Issue:3
TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
AID309025Inhibition of mashroom tyrosinase
AID1717728Competitive inhibition of recombinant human tyrosinase expressed in baculovirus infected sf9 cells using L-DOPA as substrate by double-reciprocal plot analysis2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1601772Inhibition of DOHH (unknown origin)2019European journal of medicinal chemistry, Mar-01, Volume: 165Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective.
AID312522Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum2008Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
In search of novel agents for therapy of tropical diseases and human immunodeficiency virus.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID312522Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum2008Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
In search of novel agents for therapy of tropical diseases and human immunodeficiency virus.
AID312529Antitrypanosomal activity against Trypanosoma brucei brucei TC2212008Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
In search of novel agents for therapy of tropical diseases and human immunodeficiency virus.
AID312521Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum2008Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
In search of novel agents for therapy of tropical diseases and human immunodeficiency virus.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (359)

TimeframeStudies, This Drug (%)All Drugs %
pre-199054 (15.04)18.7374
1990's94 (26.18)18.2507
2000's97 (27.02)29.6817
2010's89 (24.79)24.3611
2020's25 (6.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.62 (24.57)
Research Supply Index5.87 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index63.62 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials1 (0.28%)5.53%
Reviews2 (8.33%)6.00%
Reviews7 (1.98%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other22 (91.67%)84.16%
Other345 (97.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]